NEW! Our biotech finance handbook is now available!


 

Now available on amazon!

THE PHARMAGELLAN GUIDE TO BIOTECH FORECASTING AND VALUATION is the one-stop reference you need, whether you’re making investment decisions, pitching to potential partners, or estimating the value of an R&D program.

  • Vetted benchmarks for key drivers of income, expenses, and valuation.
  • Proprietary analyses from Pharmagellan’s experienced consulting team.
  • More than 150 current references from peer-reviewed research, industry white papers, and SEC filings.

"Deserves a spot on the bookshelf of every biotech CFO."

- Bruce Booth, Partner, Atlas Venture

 

Free sample chapter: Projecting Market Share for R&D-Stage Biotechs

Read the table of contents and get more details here

 

buy it on amazon